WVE (STOCKS)
Wave Life Sciences Ltd. Ordinary Shares
$5.390000
+0.150000 (+2.86%)
Prev close: $5.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul B. Bolno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,023.66M
- Employees
- 288
- P/E (TTM)
- -4.82
- P/B (TTM)
- 2.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.34 | $-0.31 | -0.0279 | -8.94% |
|
Mar 2026 (Q1)
|
$-0.13 | $-0.33 | +0.2011 | +60.74% |
|
Dec 2025 (Q4)
|
$-0.30 | $-0.27 | -0.0272 | -9.97% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.30 | -0.0187 | -6.21% |
Financial Statements
| Revenues | $65.37M |
| Benefits Costs and Expenses | $267.84M |
| Costs And Expenses | $262.63M |
| Nonoperating Income/Loss | $15.45M |
| Operating Expenses | $283.29M |
| Research and Development | $197.42M |
| Other Operating Expenses | $85.87M |
| Operating Income/Loss | -$217.92M |
| Income/Loss From Continuing Operations After Tax | -$202.47M |
| Income/Loss From Continuing Operations Before Tax | -$202.47M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$202.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$202.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$202.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.08 |
| Diluted Earnings Per Share | -$1.08 |
| Basic Average Shares | 373,714,379 |
| Diluted Average Shares | 373,714,379 |
| Assets | $558.32M |
| Current Assets | $507.51M |
| Cash | $490.60M |
| Prepaid Expenses | $12.12M |
| Other Current Assets | $4.79M |
| Noncurrent Assets | $50.81M |
| Fixed Assets | $6.83M |
| Other Non-current Assets | $43.98M |
| Liabilities | $104.80M |
| Current Liabilities | $50.82M |
| Accounts Payable | $20.36M |
| Wages | $10.37M |
| Other Current Liabilities | $20.08M |
| Noncurrent Liabilities | $53.99M |
| Equity | $453.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $453.52M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $558.32M |
| Net Cash Flow From Operating Activities | -$191.58M |
| Net Cash Flow From Operating Activities, Continuing | -$191.58M |
| Net Cash Flow From Investing Activities | -$124.14M |
| Net Cash Flow From Investing Activities, Continuing | -$124.14M |
| Net Cash Flow From Financing Activities | $475.24M |
| Net Cash Flow From Financing Activities, Continuing | $475.24M |
| Net Cash Flow | $159.53M |
| Net Cash Flow, Continuing | $159.53M |
| Comprehensive Income/Loss | -$202.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$202.48M |
| Other Comprehensive Income/Loss | -$11.00K |